These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 10426543)
1. Temporal evolution of 3-nitropropionic acid-induced neurodegeneration in the rat brain by T2-weighted, diffusion-weighted, and perfusion magnetic resonance imaging. Chyi T; Chang C Neuroscience; 1999; 92(3):1035-41. PubMed ID: 10426543 [TBL] [Abstract][Full Text] [Related]
2. Neuroprotective effect of lamotrigine and MK-801 on rat brain lesions induced by 3-nitropropionic acid: evaluation by magnetic resonance imaging and in vivo proton magnetic resonance spectroscopy. Lee WT; Shen YZ; Chang C Neuroscience; 2000; 95(1):89-95. PubMed ID: 10619465 [TBL] [Abstract][Full Text] [Related]
3. Temporal changes of cerebral metabolites and striatal lesions in acute 3-nitropropionic acid intoxication in the rat. Lee WT; Lee CS; Pan YL; Chang C Magn Reson Med; 2000 Jul; 44(1):29-34. PubMed ID: 10893518 [TBL] [Abstract][Full Text] [Related]
4. Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies. Ouary S; Bizat N; Altairac S; Ménétrat H; Mittoux V; Condé F; Hantraye P; Brouillet E Neuroscience; 2000; 97(3):521-30. PubMed ID: 10828534 [TBL] [Abstract][Full Text] [Related]
5. Magnetic resonance imaging of changes elicited by status epilepticus in the rat brain: diffusion-weighted and T2-weighted images, regional blood volume maps, and direct correlation with tissue and cell damage. Fabene PF; Marzola P; Sbarbati A; Bentivoglio M Neuroimage; 2003 Feb; 18(2):375-89. PubMed ID: 12595191 [TBL] [Abstract][Full Text] [Related]
6. Quantifiable bradykinesia, gait abnormalities and Huntington's disease-like striatal lesions in rats chronically treated with 3-nitropropionic acid. Guyot MC; Hantraye P; Dolan R; Palfi S; Maziére M; Brouillet E Neuroscience; 1997 Jul; 79(1):45-56. PubMed ID: 9178864 [TBL] [Abstract][Full Text] [Related]
7. Effects of alpha-phenyl-tert-butyl nitrone on neuronal survival and motor function following intrastriatal injections of quinolinate or 3-nitropropionic acid. Nakao N; Brundin P Neuroscience; 1997 Feb; 76(3):749-61. PubMed ID: 9135048 [TBL] [Abstract][Full Text] [Related]
9. Oral Dyskinesias and striatal lesions in rats after long-term co-treatment with haloperidol and 3-nitropropionic acid. Andreassen OA; Ferrante RJ; Beal MF; Jørgensen HA Neuroscience; 1998 Dec; 87(3):639-48. PubMed ID: 9758230 [TBL] [Abstract][Full Text] [Related]
10. Does diffusion-weighted magnetic resonance imaging enable detection of early ischemic change following transient cerebral ischemia? Kawahara H; Takeda Y; Tanaka A; Nagano O; Katayama H; Hirakawa M; Hiraki Y J Neurol Sci; 2000 Dec; 181(1-2):73-81. PubMed ID: 11099715 [TBL] [Abstract][Full Text] [Related]
11. Effect of 3-nitropropionic acid on kynurenine aminotransferase in the rat brain. Csillik A; Knyihár E; Okuno E; Krisztin-Péva B; Csillik B; Vécsei L Exp Neurol; 2002 Sep; 177(1):233-41. PubMed ID: 12429225 [TBL] [Abstract][Full Text] [Related]
12. Metabolic alterations produced by 3-nitropropionic acid in rat striata and cultured astrocytes: quantitative in vitro 1H nuclear magnetic resonance spectroscopy and biochemical characterization. Tsai MJ; Goh CC; Wan YL; Chang C Neuroscience; 1997 Aug; 79(3):819-26. PubMed ID: 9219944 [TBL] [Abstract][Full Text] [Related]
13. Partial inhibition of brain succinate dehydrogenase by 3-nitropropionic acid is sufficient to initiate striatal degeneration in rat. Brouillet E; Guyot MC; Mittoux V; Altairac S; Condé F; Palfi S; Hantraye P J Neurochem; 1998 Feb; 70(2):794-805. PubMed ID: 9453576 [TBL] [Abstract][Full Text] [Related]
14. Diffusion- and T2-weighted increases in magnetic resonance images of immature brain during hypoxia-ischemia: transient reversal posthypoxia. Tuor UI; Kozlowski P; Del Bigio MR; Ramjiawan B; Su S; Malisza K; Saunders JK Exp Neurol; 1998 Apr; 150(2):321-8. PubMed ID: 9527902 [TBL] [Abstract][Full Text] [Related]
15. Diffusion-weighted MR of the brain: methodology and clinical application. Mascalchi M; Filippi M; Floris R; Fonda C; Gasparotti R; Villari N Radiol Med; 2005 Mar; 109(3):155-97. PubMed ID: 15775887 [TBL] [Abstract][Full Text] [Related]
16. Temporal evolution of NMDA-induced excitoxicity in the neonatal rat brain measured with 1H nuclear magnetic resonance imaging. Verheul HB; Balázs R; Berkelbach van der Sprenkel JW; Tulleken CA; Nicolay K; van Lookeren Campagne M Brain Res; 1993 Aug; 618(2):203-12. PubMed ID: 8374753 [TBL] [Abstract][Full Text] [Related]
17. Diffusion-weighted imaging of kainic acid lesions in the rat brain. King MD; van Bruggen N; Ahier RG; Cremer JE; Hajnal JV; Williams SR; Doran M Magn Reson Med; 1991 Jul; 20(1):158-64. PubMed ID: 1943656 [TBL] [Abstract][Full Text] [Related]
18. T1 and T2 weighted magnetic resonance imaging of excitotoxin lesions and neural transplants in rat brain in vivo. Norman AB; Thomas SR; Pratt RG; Samaratunga RC; Sanberg PR Exp Neurol; 1990 Aug; 109(2):164-70. PubMed ID: 2143139 [TBL] [Abstract][Full Text] [Related]
19. SB 234551 selective ET(A) receptor antagonism: perfusion/diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection. Legos JJ; Lenhard SC; Haimbach RE; Schaeffer TR; Bentley RG; McVey MJ; Chandra S; Irving EA; Andrew A Parsons ; Barone FC Exp Neurol; 2008 Jul; 212(1):53-62. PubMed ID: 18462720 [TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance imaging and spectroscopy in assessing 3-nitropropionic acid-induced brain lesions: an animal model of Huntington's disease. Lee WT; Chang C Prog Neurobiol; 2004 Feb; 72(2):87-110. PubMed ID: 15063527 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]